Hemab ApS: Clinical Trials

9 trials sponsored by Hemab ApS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting, 2 completed, 1 active not recruiting, 1 unknown. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Recruiting 2, Active not recruiting 1
Phase 23Recruiting 2, Active not recruiting 1

Follow Hemab ApS: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers
HMB-003, Placebo - Healthy Adult Participants
Phase 1RecruitingHemab ApS402026-08-172026-09-10
A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency
Sutacimig - Congenital Factor VII Deficiency
Phase 2RecruitingHemab ApS182026-03-112026-07-22
A Study Assessing HMB-002 in Participants With Von Willebrand Disease
HMB-002 (Part A), HMB-002 (Part B), HMB-002 with Concomitant Factor Concentrate (Part C) (Not Applicable in US) - Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1
Phase 1 / Phase 2RecruitingHemab ApS1082025-02-062026-06-30
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Clinical outcomes of patients with VWD, Type 1, Clinical outcomes of patients with VWD, Type 2A, Type 2M, Type 2N, or Type 3 - Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1
RecruitingHemab ApS2002024-08-302026-04-21
The Lived Experience of People With Von Willebrand Disease
Online Survey, Qualitative Interview, Bleed Diary - Von Willebrand Diseases
CompletedHaemnet6112023-12-082025-09-18
A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia
HMB-001 - Glanzmann Thrombasthenia
Phase 1 / Phase 2Active not recruitingHemab ApS572022-12-132026-09-25
Are Uterine Fibroids Pro-thrombotic?
Comparison of blood samples between the two groups - Leiomyoma, Uterine, Thrombosis
UnknownKing's College Hospital NHS Trust1052022-10-172024-06-11
The Experiences of People Who Live With Glanzmanns Thrombasthenia.
survey and interview - Glanzmann Thrombasthenia
CompletedHaemnet1222022-04-272024-03-13
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Hematologic Disorder, Bleeding Disorder
RecruitingAmerican Thrombosis and Hemostasis Network30002020-09-302026-08-17

Conditions studied

von Willebrand Diseases (4)  ·  Thrombasthenia (2)  ·  Thrombosis (2)  ·  von Willebrand Disease, Type 3 (2)  ·  Anemia, Sickle Cell (1)  ·  Blood Platelet Disorders (1)  ·  Connective Tissue Diseases (1)  ·  Factor VII Deficiency (1)  ·  Hematologic Diseases (1)  ·  Hemophilia A (1)  ·  Hemophilia B (1)  ·  Hemostatic Disorders (1)  ·  Leiomyoma (1)  ·  Thalassemia (1)  ·  Thrombophilia (1)

Interventions

Interviews as Topic (1)  ·  Sarcoglycans (1)  ·  Surveys and Questionnaires (1)

Countries

United Kingdom (7)  ·  United States (5)  ·  Australia (2)  ·  Belgium (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)

Top investigators

Michael Recht, MD, PhD, MBA (1)  ·  Mike Holland, BSC (1)  ·  Simon Fletcher, MA (1)  ·  Tammuella Chrisentery-Singleton, MD (1)